NO953785L - 4-arylisoindol-analgesika - Google Patents

4-arylisoindol-analgesika

Info

Publication number
NO953785L
NO953785L NO953785A NO953785A NO953785L NO 953785 L NO953785 L NO 953785L NO 953785 A NO953785 A NO 953785A NO 953785 A NO953785 A NO 953785A NO 953785 L NO953785 L NO 953785L
Authority
NO
Norway
Prior art keywords
double blend
stereo
carbon
joins
double
Prior art date
Application number
NO953785A
Other languages
English (en)
Norwegian (no)
Other versions
NO953785D0 (no
Inventor
Richard J Carmosin
John Robert Carson
Dennis C Liotta
Philip Pitis
Robert B Raffa
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO953785D0 publication Critical patent/NO953785D0/no
Publication of NO953785L publication Critical patent/NO953785L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO953785A 1993-03-26 1995-09-25 4-arylisoindol-analgesika NO953785L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3857193A 1993-03-26 1993-03-26
US9996593A 1993-07-29 1993-07-29
US08/173,586 US5508424A (en) 1993-03-26 1993-12-23 4-arylisoindole analgesics
PCT/US1994/003329 WO1994022823A1 (fr) 1993-03-26 1994-03-28 Analgesiques a base de 4-arylisoindole

Publications (2)

Publication Number Publication Date
NO953785D0 NO953785D0 (no) 1995-09-25
NO953785L true NO953785L (no) 1995-09-25

Family

ID=27365417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953785A NO953785L (no) 1993-03-26 1995-09-25 4-arylisoindol-analgesika

Country Status (19)

Country Link
US (1) US5508424A (fr)
EP (1) EP0690842B1 (fr)
JP (1) JP3326180B2 (fr)
CN (1) CN1123546A (fr)
AT (1) ATE174588T1 (fr)
AU (1) AU674746B2 (fr)
BG (1) BG100017A (fr)
CA (1) CA2159071C (fr)
CZ (1) CZ248195A3 (fr)
DE (1) DE69415307T2 (fr)
DK (1) DK0690842T3 (fr)
ES (1) ES2126750T3 (fr)
FI (1) FI954537A7 (fr)
GR (1) GR3029534T3 (fr)
HU (1) HUT74087A (fr)
NO (1) NO953785L (fr)
PL (1) PL310829A1 (fr)
SK (1) SK118295A3 (fr)
WO (1) WO1994022823A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543530A (en) * 1993-12-23 1996-08-06 Ortho Pharmaceutical Corporation 4-arylisoindole analgesics
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics
US5602167A (en) * 1995-05-17 1997-02-11 Ortho Pharmaceutical Corporation 4-arylcyclohepta[c] pyrrole analgesics
US6846783B2 (en) * 2000-06-22 2005-01-25 The Lubrizol Corporation Acylatign agents and dispersants for lubricating oil and fuels
US7135484B2 (en) 2002-08-14 2006-11-14 Abbott Laboratories Azabicyclic compounds are central nervous system active agents
CA2495589A1 (fr) * 2002-08-14 2004-02-26 Abbott Laboratories Composes azabicycliques comme agents actifs du systeme nerveux central
US7700597B2 (en) 2004-12-03 2010-04-20 Schering Corporation Substituted piperazines as CB1 antagonists
WO2007084450A2 (fr) * 2006-01-18 2007-07-26 Schering Corporation Modulateurs de recepteurs de cannibinoides
WO2008130616A2 (fr) * 2007-04-19 2008-10-30 Schering Corporation Diaryl morpholines comme modulateurs des récepteurs cb1
CN101790521A (zh) * 2007-06-28 2010-07-28 英特维特国际股份有限公司 作为cb1拮抗剂的取代哌嗪
WO2009005646A2 (fr) * 2007-06-28 2009-01-08 Schering Corporation Pipérazines à substitution servant d'antagonistes des récepteurs cb1
CN104513172B (zh) * 2013-09-30 2018-02-02 天士力医药集团股份有限公司 含有三氟甲基的酰胺生物碱、制备方法及其药物用途
US10906888B2 (en) 2016-07-14 2021-02-02 Pfizer Inc. Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
CN112010859B (zh) * 2019-05-30 2022-07-19 中国科学院上海药物研究所 一种并环化合物、其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042707A (en) * 1976-02-19 1977-08-16 E. I. Du Pont De Nemours And Company 3α-Arylhydroisoindoles
US4689329A (en) * 1986-02-04 1987-08-25 Mcneilab, Inc. 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
FR2676442B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2676443B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole et leur preparation.
US5216018A (en) * 1992-02-14 1993-06-01 Du Pont Merck Pharmaceutical Company Hydroisoindolines and hydroisoquinolines as psychotropic
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate

Also Published As

Publication number Publication date
HUT74087A (en) 1996-11-28
CZ248195A3 (en) 1996-02-14
NO953785D0 (no) 1995-09-25
PL310829A1 (en) 1996-01-08
AU674746B2 (en) 1997-01-09
ATE174588T1 (de) 1999-01-15
CN1123546A (zh) 1996-05-29
DE69415307D1 (de) 1999-01-28
CA2159071A1 (fr) 1994-10-13
SK118295A3 (en) 1996-06-05
JP3326180B2 (ja) 2002-09-17
FI954537L (fi) 1995-10-27
DE69415307T2 (de) 1999-06-17
WO1994022823A1 (fr) 1994-10-13
ES2126750T3 (es) 1999-04-01
EP0690842B1 (fr) 1998-12-16
FI954537A0 (fi) 1995-09-25
CA2159071C (fr) 2005-06-28
GR3029534T3 (en) 1999-06-30
DK0690842T3 (da) 1999-08-23
US5508424A (en) 1996-04-16
HU9502793D0 (en) 1995-11-28
BG100017A (bg) 1996-04-30
AU6493394A (en) 1994-10-24
FI954537A7 (fi) 1995-10-27
JPH08509212A (ja) 1996-10-01
EP0690842A1 (fr) 1996-01-10

Similar Documents

Publication Publication Date Title
AU571225B2 (en) Retro-inverso analogues of the bradykinin potentiating peptide bpp 5a
NO174508C (fr)
TR199700470A2 (xx) Sildenafilin haz�rlanmas� i�in proses.
HU905605D0 (en) Substituted imidazoles
MY102986A (en) Benzo (5,6) cycloheptapyridines, compositions and methods of use
PT85312A (en) Process for the preparation of angiotension ii receptor blocking imidazoles and of pharmaceutical
CA2063926A1 (fr) Imidazopyridine
ES2184762T3 (es) Allquil bencilaminoquinuclidinas sustituidas con heteroatomos como antagonista de la sustancia p'.
ES2067248T3 (es) Derivados de indol como agentes antialergicos y antiinflamatorios.
NO860332L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydro-tieno(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.
NZ336196A (en) Use of green porphyrins for the treatment of secondary cataracts
EP0276543A3 (fr) Emploi de buspirone pour l'amélioration de la mémoire à court terme
ES8507540A1 (es) Un procedimiento para preparar indeno-piridazinonas sustituidas.
BR9100767A (pt) Composto,formulacao farmaceutica e metodo para a preparacao de hipurato de 4-(di-n-propil)amino-1,3,4,5-tetrahidrobenz(cd)indol cristalino
EP0366135A3 (en) Semiconductor laser arrangement for high output power in the lateral dominant mode
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
CA2159071A1 (fr) Analgesiques de type 4-arylisoindole
GR3036287T3 (en) Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
DE69712338D1 (de) Zusammensetzung auf basis von enalapril und losartan
FR2642755B1 (fr)
AU8831391A (en) Chroman derivatives
IE890244L (en) Protecting tissue from reperfusion injury
MY129947A (en) Novel substituted thienopyrans as antihypertensive agents.
Singh et al. Effect of melatonin and beta-carotene on indomethacin induced gastric mucosal injury